2016 Aug 12;81(156):53846-8.
Abstract
To facilitate research involving marijuana and its chemical constituents, DEA is adopting a new policy that is designed to increase the number of entities registered under the Controlled Substances Act (CSA) to grow (manufacture) marijuana to supply legitimate researchers in the United States. This policy statement explains how DEA will evaluate applications for such registration consistent with the CSA and the obligations of the United States under the applicable international drug control treaty.
- PMID: 27529905
- [PubMed – indexed for MEDLINE]
-
MeSH Terms, Substances